FIJYX Mutual Fund

FIJYX Mutual Fund (Fidelity Advisor Biotechnology Fund Class Z) is managed by Fidelity Investments (US) with $214.6M in net assets. FIJYX expense ratio is 0.57%, holding 131 positions across sectors including Health Care, Financials, Industrials. Inception date: 2018-10-02.

FIJYX performance shows a YTD return of 29.70%. The 1-year return is 35.89% and the 5-year return is 13.44%. FIJYX dividend yield stands at 0.93%, paid annually.

FIJYX top holdings include Abbvie Inc. (13.8%), Gilead Sciences (6.0%), Alnylam Pharmaceuticals Inc. (3.8%), Insmed Inc (3.4%), Amylyx Pharmaceuticals Inc (3.4%). Go to all FIJYX holdings, FIJYX sectors, or FIJYX dividends.

FIJYX can be compared against other funds. Use FIJYX overlap to find shared positions, or FIJYX vs another fund for a side-by-side view. FIJYX alternatives are available via the screener, along with tax-loss harvesting opportunities.